Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial (Q33340785)
scientific article
Language:
Current Data About Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial
(P31) (Q13442814)
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P304) 2-8
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P433) 1
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P478) 62
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P577) Tuesday, January 1, 2002
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P921) (Q42824440)

(Q12859063)
(P887)

(P1433) (Q2016300)
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P1476) "Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial" (language: en)
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

(P2093) M Blackstein
(P1545) 1
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

C L Vogel
(P1545) 2
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

R Ambinder
(P1545) 3
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

J Cowan
(P1545) 4
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

J Iglesias
(P1545) 5
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

A Melemed
(P1545) 6
(P248)
(P698) 11810037
(P813) Tuesday, July 25, 2017

other details
description scientific article

External Links
(P356) 10.1159/000048240
(P698) 11810037